ROCKVILLE, Md., July 6, 2016 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused on developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases, announced today that Jeffrey Riley, President & Chief Executive Officer, is scheduled to present at the 2nd Annual Cantor Fitzgerald Annual Healthcare Conference being held July 12-13 at Le Parker Meridien in New York, NY. Mr. Riley is scheduled to present on Wednesday, July 13, 2016 at 3:00 p.m. ET.
A live webcast of Synthetic Biologics' presentation may be accessed by logging onto the web at http://wsw.com/webcast/cantor4/syn. After the presentation, a replay will be archived and accessible for 90 days at the same website.